Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NoctoPlex is a drug-free, non-habit-forming sleep dietary supplement formulated as a proprietary blend of primarily natural ingredients to improve the onset, duration, and quality of sleep.[2][5] Marketed originally by Union Springs Healthcare and later acquired into Enzymotec’s VAYA Pharma portfolio, and now sold by Medella Springs Healthcare, it is positioned as a clinically formulated sleep aid that promotes natural relaxation, calms a racing mind, relieves tension and minor discomfort, and helps reset the sleep cycle without next‑day grogginess.[1][2][4][5] The exact ingredient composition and molecular targets are not publicly disclosed, but marketing materials emphasize multi‑mechanistic support of GABAergic and relaxation pathways through botanicals and other natural sleep-supportive compounds.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on NoctoPlex.